You are here

  • Home
  • Archive
  • Volume 80, Issue 2
  • Response to: ‘Patients with lupus are not protected from COVID-19: a comment’ by Sawalha, ‘No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit’ by Romão et al and ‘SLE patien…

Article Text

Article menu
Download PDFPDF
Correspondence response
Response to: ‘Patients with lupus are not protected from COVID-19: a comment’ by Sawalha, ‘No evidence so far on the protective effect of hydroxycloroquin to prevent COVID-19: response to the Comment by Joob and Wiwanitkit’ by Romão et al and ‘SLE patients are not immune to COVID-19: importance of sending the right message across’ by Goyal
  1. Beuy Joob1,
  2. Viroj Wiwanitkit2
  1. 1 Sanitation 1 Medical Academic Center, Bangkok, Thailand
  2. 2 Department of Community Medicine, Dr DY Patil University, Pune, India
  1. Correspondence to Dr Beuy Joob, Sanitation 1 Medical Academic Center, Bangkok, Thailand; beuyjoob{at}hotmail.com

https://doi.org/10.1136/annrheumdis-2020-217695

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We thank the readers who share interesting ideas on our publication entitled ‘SLE, hydroxychloroquine and no SLE patients with COVID-19: a comment’.1 First, we really appreciate the reply by Monti and Montecucco.2 We agree that large registry data are required to clarify the incidence of COVID-19 in patients with systemic lupus erythematosus (SLE).1 Seeking for a new drug against the emerging COVID-19 is a challenge. In this pandemic situation, urgent search for drug and vaccine is necessary. Not only hydroxychloroquine but also other drugs such as antiretroviral drugs are widely used without complete clinical trials. We feel glad that our article can stimulate data sharing on the important issue of the inter-relationship between COVID-19, SLE …

    View Full Text

    Footnotes

    • Handling editor Josef S Smolen

    • Contributors BJ and VW contributed equally. Both authors conceived the idea, participated in the analysis and writing, and approved the article for final submission.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests None declared.

    • Patient and public involvement Patients and/or the public were not involved in the design, or conduct, or reporting, or dissemination plans of this research.

    • Patient consent for publication Not required.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles